Siglec‐F is induced by granulocyte–macrophage colony‐stimulating factor and enhances interleukin‐4‐induced expression of arginase‐1 in mouse macrophages

Hiroyuki Tateyama,Yusuke Murase,Hiroshi Higuchi,Yui Inasaka,Hidenori Kaneoka,Shinji Iijima,Ken‐ichi Nishijima

DOI: https://doi.org/10.1111/imm.13121

2019-10-17

Immunology

Abstract:Siglecs are cell surface lectins that recognize sialic acids and are primarily expressed in hematopoietic cells. Previous studies showed that some Siglecs regulate macrophage function. In the present study, we examined the induction and putative roles of mouse Siglec‐F in bone marrow‐derived macrophages in mice. A quantitative RT‐PCR analysis showed that the basal expression of Siglec‐F was weak in bone marrow‐derived macrophages differentiated by M‐CSF. However, a 24‐h stimulation with GM‐CSF enhanced Siglec‐F expression. GM‐CSF also enhanced Siglec‐F expression in thioglycollate‐induced peritoneal macrophages. The inhibition of STAT5, but not that of PI3K or MEK, significantly reduced the induction of Siglec‐F. IL‐3, which uses a common β chain shared with the GM‐CSF receptor to stimulate the STAT5 pathway, also enhanced Siglec‐F expression. The knockdown of Siglec‐F by a specific siRNA enhanced GM‐CSF‐induced STAT5 phosphorylation, suggesting that Siglec‐F down‐regulates its own expression upon prolonged GM‐CSF stimulation. Furthermore, the knockdown of Siglec‐F reduced the STAT6 phosphorylation and expression of arginase‐1 in IL‐4‐stimulated macrophages. These results suggest that Siglec‐F fine‐tunes immune responses of macrophages.

immunology